灯盏细辛注射液治疗冠心病心绞痛31例

Erigeron breviscapus injectio in the treatment of coronary heart disease with angina pectoris in 31 patients

本文报道应用灯盏细辛注射液治疗冠心病心绞痛31例(男性18例,女性13例;年龄60±11yr)的疗效。结果:灯盏细辛注射液(80mg/d)静脉滴注2wk后,临床疗效为87％,心电图疗效为71％。另外,对15例冠心病心绞痛患者采用复方丹参16mL加入葡萄糖液500mL静脉滴注,qd,2wk后,临床疗效80％,心电图疗效40％;2组比较,疗效相似。

In 46 patients suffered from coronary disease with angina pectoris, 31 patients (M18, F13; age 60±11yr) received Erigeron breviscapus 80mg in 10% glucose 500mL iv gtt qd×14, the clinical efficacy was 87% and the ECG efficacy was 11%. While the other 15 patients received Fufang Danshen injection 16mL(2mL/Amp, each Amp consist of Salvia miltiorrhiza Ig and Dalbergia odorifera Ig) in 10% glucose 500mL iv gtt qd×14 as control, the clinical efficacy was 80%, and the ECG efficacy was 40%, the ECG efficacy of Erigeron breviscapus was higher than that of Fufang Danshen, but no statistical significance (P>0.05).